Recruitment of the mitochondria-dependent apoptotic pathway in amyotrophic lateral sclerosis

Journal of Neuroscience

Volumn 21, Issue 17, 2001, Pages 6569-6576

  Guégan, Christelle ^a   Vila, Miquel ^a   Rosoklija, Gorazd ^a   Hays, Arthur P ^a   Przedborski, Serge ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Amyotrophic lateral sclerosis; Apoptosis; Bax; Caspase; Cytochrome c; Mitochondria; Neurodegeneration; Superoxide dismutase

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 7; CASPASE 9; CYTOCHROME C; PROTEIN BAX; SUPEROXIDE DISMUTASE; BAX PROTEIN, HUMAN; BAX PROTEIN, MOUSE; BIRC4 PROTEIN, HUMAN; CASP7 PROTEIN, HUMAN; CASP7 PROTEIN, MOUSE; CASP9 PROTEIN, HUMAN; CASP9 PROTEIN, MOUSE; CASPASE; COPPER ZINC SUPEROXIDE DISMUTASE; ONCOPROTEIN; PROTEIN; PROTEIN BCL 2; X LINKED INHIBITOR OF APOPTOSIS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; DISEASE COURSE; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MOTONEURON; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SPINAL CORD; TRANSGENIC MOUSE; ANIMAL; CYTOSOL; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; PATHOLOGY; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 7; CASPASE 9; CASPASES; CYTOCHROME C GROUP; CYTOSOL; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MITOCHONDRIA; PROTEIN TRANSPORT; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPINAL CORD; SUPEROXIDE DISMUTASE; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0035437866     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-17-06569.2001     Document Type: Article

References (52)

1. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis
2. Superoxide dismutase in familial amyotrophic lateral sclerosis: Models for gain of function
3. Mechanisms of selective motor neuron death in ALS: Insights from transgenic mouse models of motor neuron disease
4. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS)
5. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase
6. IAP family proteins - Suppressors of apoptosis
7. X-linked IAP is a direct inhibitor of cell-death proteases
8. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
9. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
10. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
11. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL
12. Inhibition of ICE slows ALS in mice
13. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal ischemia in mice
14. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice
15. Activation of CPP-32 protease in hippocampal neurons following ischemia and epilepsy
16. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
17. Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice
18. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
19. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis
20. Bax directly induces release of cytochrome c from isolated mitochondria
21. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
22. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
23. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia
24. Mitochondrial control of cell death
25. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS)
26. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
27. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
28. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
29. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
30. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
31. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture
32. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
33. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis
34. IAP family proteins delay motoneuron cell death in vivo
35. Neuronal cell death
36. Brain superoxide dismutase, catalase and glutathione peroxidase activites in amyotrophic lateral sclerosis
37. BAX translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, BCL-2, and caspases
38. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
39. Hereditary and acquired motor neuron diseases
40. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
41. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation
42. Apoptosis in Alzheimer's disease - An update
43. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
44. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
45. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1
46. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis
47. Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis
48. Movement of Bax from the cytosol to mitochondria during apoptosis
49. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosomelinked inhibitor of apoptosis protein overexpression in the rat hippocampus
50. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury
51. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3